SVNT Financial Facts
Loss before income taxes: -20.43MCost of goods sold: 1.42M
See Full Income Statement
Total current assets: 47.38M
Cash and cash equivalents: 28.44M
See Full Balance Sheet
Savient Pharmaceuticals, Inc. (SVNT) Earnings
|
Expand Research on SVNT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -7.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/3/11  |
 |
Q311 | -$0.39 | -$0.40 | +$0.01 | $2.58M | $3.17M | N/A |  | | Details |
| 8/4/11 |
|
Q211 | -$0.43 | -$0.30 | -$0.13 | $2M | $2.77M | N/A | | | Details |
| 5/5/11 |
|
Q111 | -$0.19 | -$0.31 | +$0.12 | $1.29M | $2.09M | N/A | | | Details |
| 2/25/11 |
|
Q410 | -$0.01 | -$0.26 | +$0.25 | $1M | $1.01M | N/A | | | Details |
| 2/27/12 |
|
Q411 | -$0.44 | -$0.38 | -$0.06 | $3.71M | $3.51M | N/A | | | Details |
| 5/9/12 |
Q112 | -$0.49 | -$0.46 | -$0.03 | $3.5M | $4.59M | N/A | | | Details | |
| 5/15/13 | Q113 | -$0.34 | -$0.31 | -$0.03 | $4.7M | $5.65M | N/A | | | Details | |
| 3/19/13 |
|
Q412 | -$0.39 | -$0.44 | +$0.05 | $4.95M | $6.18M | N/A | | | Details |
